SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044538
Filing Date
2024-11-12
Accepted
2024-11-12 08:05:36
Documents
73
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1213173
2 ex3-1.htm EX-3.1 17510
3 ex3-2.htm EX-3.2 72959
4 ex31-1.htm EX-31.1 17955
5 ex31-2.htm EX-31.2 17879
6 ex32-1.htm EX-32.1 9151
7 ex32-2.htm EX-32.2 9324
  Complete submission text file 0001493152-24-044538.txt   7131264

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE nrxs-20240930.xsd EX-101.SCH 47580
9 XBRL CALCULATION FILE nrxs-20240930_cal.xml EX-101.CAL 58539
10 XBRL DEFINITION FILE nrxs-20240930_def.xml EX-101.DEF 265862
11 XBRL LABEL FILE nrxs-20240930_lab.xml EX-101.LAB 457214
12 XBRL PRESENTATION FILE nrxs-20240930_pre.xml EX-101.PRE 391537
76 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1048685
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

IRS No.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41775 | Film No.: 241443556
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)